NEOG
Price
$15.78
Change
+$0.32 (+2.07%)
Updated
Mar 28, 6:59 PM EST
12 days until earnings call
PEN
Price
$223.41
Change
-$2.75 (-1.22%)
Updated
Mar 28, 6:59 PM EST
33 days until earnings call
Ad is loading...

Compare trend and price NEOG vs PEN

Header iconNEOG vs PEN Comparison
Open Charts NEOG vs PENBanner chart's image
Neogen
Price$15.78
Change+$0.32 (+2.07%)
Volume$669.02K
CapitalizationN/A
Penumbra
Price$223.41
Change-$2.75 (-1.22%)
Volume$129.87K
CapitalizationN/A
View a ticker or compare two or three
NEOG vs PEN Comparison Chart

Loading...

NEOGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
NEOG vs. PEN commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEOG is a Hold and PEN is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (NEOG: $15.78 vs. PEN: $223.41)
Brand notoriety: NEOG and PEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEOG: 41% vs. PEN: 37%
Market capitalization -- NEOG: $3.35B vs. PEN: $8.76B
NEOG [@Medical Specialties] is valued at $3.35B. PEN’s [@Medical Specialties] market capitalization is $8.76B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEOG’s FA Score shows that 0 FA rating(s) are green whilePEN’s FA Score has 0 green FA rating(s).

  • NEOG’s FA Score: 0 green, 5 red.
  • PEN’s FA Score: 0 green, 5 red.
According to our system of comparison, PEN is a better buy in the long-term than NEOG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEOG’s TA Score shows that 6 TA indicator(s) are bullish while PEN’s TA Score has 4 bullish TA indicator(s).

  • NEOG’s TA Score: 6 bullish, 2 bearish.
  • PEN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NEOG is a better buy in the short-term than PEN.

Price Growth

NEOG (@Medical Specialties) experienced а +2.14% price change this week, while PEN (@Medical Specialties) price change was -1.82% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.79%. For the same industry, the average monthly price growth was -0.28%, and the average quarterly price growth was +4.33%.

Reported Earning Dates

NEOG is expected to report earnings on Jul 23, 2024.

PEN is expected to report earnings on Apr 30, 2024.

Industries' Descriptions

@Medical Specialties (+0.79% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for NEOG with price predictions.
OPEN
A.I.dvisor published
a Summary for PEN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PEN($8.76B) has a higher market cap than NEOG($3.35B). NEOG has higher P/E ratio than PEN: NEOG (154.60) vs PEN (97.58). PEN YTD gains are higher at: -11.183 vs. NEOG (-21.532). NEOG has higher annual earnings (EBITDA): 189M vs. PEN (109M). PEN has more cash in the bank: 289M vs. NEOG (230M). PEN has less debt than NEOG: PEN (234M) vs NEOG (889M). PEN has higher revenues than NEOG: PEN (1.06B) vs NEOG (919M).
NEOGPENNEOG / PEN
Capitalization3.35B8.76B38%
EBITDA189M109M173%
Gain YTD-21.532-11.183193%
P/E Ratio154.6097.58158%
Revenue919M1.06B87%
Total Cash230M289M80%
Total Debt889M234M380%
FUNDAMENTALS RATINGS
NEOG vs PEN: Fundamental Ratings
NEOG
PEN
OUTLOOK RATING
1..100
5369
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
8977
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
6899
SEASONALITY SCORE
1..100
n/a32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEOG's Valuation (87) in the Medical Specialties industry is in the same range as PEN (93). This means that NEOG’s stock grew similarly to PEN’s over the last 12 months.

PEN's Profit vs Risk Rating (58) in the Medical Specialties industry is somewhat better than the same rating for NEOG (100). This means that PEN’s stock grew somewhat faster than NEOG’s over the last 12 months.

PEN's SMR Rating (77) in the Medical Specialties industry is in the same range as NEOG (89). This means that PEN’s stock grew similarly to NEOG’s over the last 12 months.

PEN's Price Growth Rating (50) in the Medical Specialties industry is in the same range as NEOG (50). This means that PEN’s stock grew similarly to NEOG’s over the last 12 months.

NEOG's P/E Growth Rating (68) in the Medical Specialties industry is in the same range as PEN (99). This means that NEOG’s stock grew similarly to PEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEOGPEN
RSI
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
54%
Bearish Trend 7 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 4 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
NEOGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VIOG112.320.63
+0.56%
Vanguard S&P Small-Cap 600 Growth ETF
QAT17.640.06
+0.34%
iShares MSCI Qatar ETF
AVSU61.430.17
+0.28%
Avantis Responsible US Equity ETF
BOUT36.390.06
+0.17%
Innovator IBD® Breakout Opps ETF
SPYG73.15-0.21
-0.29%
SPDR® Portfolio S&P 500 Growth ETF